Growth Hormone Secretagogues

CJC-1295 Reconstitution

How to mix CJC-1295 and read the exact units to draw. Enter your vial size and bacteriostatic water below for the concentration and dose on a U-100 insulin syringe.

How to reconstitute CJC-1295

  1. Swab the rubber stopper of the CJC-1295 vial and the bacteriostatic water vial with an alcohol wipe.
  2. Draw 1 ml of bacteriostatic water into a syringe.
  3. Inject it slowly down the inside wall of the CJC-1295 vial, not directly onto the powder.
  4. Swirl gently until the powder fully dissolves. Do not shake. Shaking can damage the peptide.
  5. Keep the unreconstituted vial at 2 to 8 degrees C.

CJC-1295 concentration by water volume

CJC-1295 is commonly supplied in 5 mg vials. The concentration depends only on how much bacteriostatic water you add. More water lowers the concentration and makes small doses easier to measure.

BAC water addedConcentrationPer 1 unit
1 ml5,000 mcg/ml50 mcg
2 ml2,500 mcg/ml25 mcg
3 ml1,666.7 mcg/ml16.7 mcg

CJC-1295 units to draw

At 5,000 mcg/ml (a 5 mg vial in 1 ml of bacteriostatic water), here is the draw for doses across the range CJC-1295 is typically used at. Change any number in the calculator above for your own vial.

DoseUnits to drawVolume
2 mg40 units0.40 ml
2.5 mg50 units0.50 ml
3 mg60 units0.60 ml
3.5 mg70 units0.70 ml
4.2 mg84 units0.84 ml

CJC-1295 dosing

Dosing splits by version. The no-DAC form (Mod GRF 1-29) is commonly dosed around 100 mcg subcutaneously, often once or more daily and timed with an ipamorelin dose. The DAC form is dosed much less frequently, roughly weekly, because of its long half-life. None of this is standardized or approved, and protocols vary widely from source to source. Enter your own vial size, water volume, and target dose in the calculator above to convert any CJC-1295 protocol into exact insulin-syringe units. For the full profile, see the CJC-1295 compound page.

Storing reconstituted CJC-1295

Keep the unreconstituted vial at 2 to 8 degrees C. Once mixed, refrigerate and protect from light. No in-use stability data has been published.

CJC-1295 is sold as two chemically different products under one name. The doses above are for the DAC-conjugated form, given as single subcutaneous doses of 30 to 60 mcg/kg weekly or biweekly in the Teichman 2006 trial. They do not apply to CJC-1295 without DAC (mod GRF 1-29), which is a different molecule with a half-life measured in minutes and no human dosing data. Check which one you have.

The dose range above comes from published clinical trials. CJC-1295 is not FDA-approved for this use.

The math

Prefer a full workspace? The peptide dosage & reconstitution calculator adds blend, converter, half-life, and titration tools.

CJC-1295 reconstitution FAQ

How do you reconstitute CJC-1295?

Draw 1 ml of bacteriostatic water into a syringe, inject it slowly down the inside wall of the CJC-1295 vial, and swirl gently until the powder dissolves. Do not shake. The concentration is the vial size in mg times 1,000, divided by the millilitres you added.

How much bacteriostatic water do I add to CJC-1295?

1 ml for a 5 mg vial gives 5,000 mcg/ml. More liquid makes small doses easier to measure accurately. The calculator shows the concentration for any volume you choose.

How many units of CJC-1295 do I draw?

Units to draw equals your dose in mcg divided by the concentration in mcg/ml, times 100 on a U-100 insulin syringe. At 5,000 mcg/ml, a 3 mg dose is 60 units.

How do you store reconstituted CJC-1295?

Keep the unreconstituted vial at 2 to 8 degrees C. Once mixed, refrigerate and protect from light. No in-use stability data has been published.

References

Track CJC-1295 in Peptide AI

Log your doses, connect labs and wearables, and let the AI show you how CJC-1295 is affecting your biomarkers over time.

Download the app

Educational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.